We look beyond a below par 1H21 result and recognise the opportunities for growth in future periods. With maintained underlying GP margins and overheads, plus a first-time contribution from Trivantage, full year revenue guidance signals much improved earnings in the 2H. A strong balance sheet further supports our BUY call and $0.82 valuation.
To access the full report please log in under the Client Area at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.
If you would like to access our research please contact us to create an account.
